APA (7th ed.) Citation

Lübke, J., Metzgeroth, G., Reiter, A., & Schwaab, J. (2024). Approach to the patient with eosinophilia in the era of tyrosine kinase inhibitors and biologicals. Current hematologic malignancy reports, 19(5), . https://doi.org/10.1007/s11899-024-00738-7

Chicago Style (17th ed.) Citation

Lübke, Johannes, Georgia Metzgeroth, Andreas Reiter, and Juliana Schwaab. "Approach to the Patient with Eosinophilia in the Era of Tyrosine Kinase Inhibitors and Biologicals." Current Hematologic Malignancy Reports 19, no. 5 (2024). https://doi.org/10.1007/s11899-024-00738-7.

MLA (9th ed.) Citation

Lübke, Johannes, et al. "Approach to the Patient with Eosinophilia in the Era of Tyrosine Kinase Inhibitors and Biologicals." Current Hematologic Malignancy Reports, vol. 19, no. 5, 2024, https://doi.org/10.1007/s11899-024-00738-7.